Fifth Third Bancorp
CRMD icon

Fifth Third Bancorp’s CorMedix CRMD Stock Holding History

Fifth Third Bancorp’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17K Buy
+320
New +$2.37K ﹤0.01% 4018

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fifth Third Bancorp's CRMD Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in CorMedix (CRMD) in Q1 2026: 320 shares worth $2.17K. The stake represents ﹤0.01% of the portfolio and ranks #4018 among its holdings.

187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Fifth Third Bancorp held 320 shares of CorMedix worth $2.17K as of Q1 2026.
  • CorMedix was a new Fifth Third Bancorp position in Q1 2026.
  • CorMedix made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #4018 holding.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.